Pediatrics
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
From the Journals
Most Cancer Trial Centers Located Closer to White, Affluent Populations
Researchers compare the distributions of patients of different races and socioeconomic statuses to the locations of clinical research facilities...
Commentary
New Drug Approvals Are the Wrong Metric for Cancer Policy
How should we define success in cancer policy — what should the endpoint be?
Feature
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
What are the cancer types where exercise makes a difference?
News
Pfizer Antibody-Drug Conjugate Picks Up Pediatric ALL Indication
The FDA has given pediatric approval for inotuzumab ozogamicin to treat some types of relapsed or refractory acute lymphoblastic leukemia.
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
Feature
New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?
Adults with previously untreated follicular lymphoma or diffuse large B-cell lymphoma may be eligible to participate in one of three randomized,...
Feature
Democratic Lawmakers Press Pfizer on Chemotherapy Drug Shortages
The company, which said in May that it was working to assuage critical shortages of methotrexate, carboplatin and cisplatin, is being asked to...
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
Commentary
Long-Term Follow-Up Emphasizes HPV Vaccination Importance
No cases of high-grade intraepithelial neoplasia or condyloma were seen in a study of patients who received an HPV...
Latest News
CT Poses Risk for Malignant Hematopathies Among Children
For every 10,000 children examined today (with a dose per scan of 8 mGy), 1-2 could develop a radiation-related malignant hematopathy in the next...